ADHD News Alert Alcobra Ltd (ADHD) 6.92 02/14/2015 12:00:11

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alcobra Ltd (ADHD) 6.92 $ADHD

Nasdaq stocks posting largest percentage increases
AP - Fri Feb 13, 5:13PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ADHD: 6.92 (+0.73), RCKY: 18.43 (+4.33)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ALNY: 95.54 (+1.67), BRP: 24.17 (+0.01), ADHD: 6.92 (+0.73), ALSN: 31.88 (+0.24), ACGL: 59.95 (+0.36)

Alcobra's (ADHD) CEO Yaron Daniely on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 11:45AM CST

ADHD: 6.92 (+0.73)

Alcobra Q4 & FY14 results
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 9:16AM CST

ADHD: 6.92 (+0.73)

Alcobra beats by $0.10
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:44AM CST

ADHD: 6.92 (+0.73)

Alcobra Announces Fourth Quarter and Fiscal Year 2014 Financial Results and Provides Corporate Update
GlobeNewswire - Thu Feb 12, 6:36AM CST
-- Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
ADHD: 6.92 (+0.73)

Insights From the Pharmaceutical Space: New Research on Alcobra, Alder, Aldeyra, Alexion, Alexza
PR Newswire - Tue Feb 03, 7:20AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Alcobra (NASDAQ: ADHD), Alder (NASDAQ: ALDR), Aldeyra (NASDAQ: ALDX), Alexion (NASDAQ: ALXN), and Alexza (NASDAQ: ALXA). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ALDR: 26.06 (+0.18), ALDX: 11.01 (-0.25), ADHD: 6.92 (+0.73), ALXN: 182.29 (+6.02), ALXA: 2.07 (+0.09)

Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2014 Financial Results and Host Corporate Update Conference Call & Webcast on February 12
GlobeNewswire - Mon Feb 02, 7:00AM CST
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2014 before the market open, and will host a corporate update conference call and webcast on Thursday, February 12 at 8:30am Eastern Time.
ADHD: 6.92 (+0.73)

Alcobra Ltd. to Present at BIO CEO & Investor Conference
GlobeNewswire - Thu Jan 29, 7:11AM CST
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that Dr. Yaron Daniely, President and Chief Executive Officer of Alcobra, will provide a corporate overview at the upcoming BIO CEO & Investor Conference.
ADHD: 6.92 (+0.73)

Money flow into Alcobra picks up
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 12:50PM CST

ADHD: 6.92 (+0.73)

Can the Uptrend Continue for Alcobra (ADHD)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 6:31AM CST
Can the Uptrend Continue for Alcobra (ADHD)?
ADHD: 6.92 (+0.73)

Alcobra: Options Opportunity In This Rebounding Biotech
Matt Perdue - at Seeking Alpha - Thu Jan 15, 10:03AM CST

ADHD: 6.92 (+0.73)

UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Alcobra Ltd. and a Lead Plaintiff Deadline of January 20, 2015
GlobeNewswire - Wed Jan 14, 1:16PM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Alcobra Ltd. ("Alcobra" or the "Company" (Nasdaq:ADHD) securities between March 28, 2014 and November 14, 2014.
ADHD: 6.92 (+0.73)

Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
GlobeNewswire - Wed Jan 14, 8:16AM CST
Alcobra Ltd. (Nasdaq:ADHD) today reported that it has closed its previously announced public offering of ordinary shares. The Company sold 7,475,000 ordinary shares in the offering, including 975,000 shares that were issued upon the full exercise by the underwriters of their over-allotment option. The offering price was $4.00 per share, and the net proceeds to the Company from the sale of the shares were approximately $27.9 million. Investors in the offering included Venrock, Deerfield, Broadfin Capital, Great Point Partners and others.
ADHD: 6.92 (+0.73)

Rosen Law Firm Reminds Alcobra Ltd. Investors of Important January 19, 2015 Deadline in Class Action - ADHD
GlobeNewswire - Mon Jan 12, 2:05PM CST
Rosen Law Firm reminds purchasers of Alcobra Ltd. common stock (Nasdaq:ADHD) during the period from March 28, 2014 through November 14, 2014, of the important January 19, 2015 deadline in the class action.
ADHD: 6.92 (+0.73)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 0

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 17

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 1

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 15

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Navigating Battery Compliance for AI Data Centers

Updated Category News Views 23

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 11

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 1

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 0

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 33

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 5

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

McCeil Johnson Takes Leadership Role in UPCEA Committee

Updated Category News Views 218

McCeil Johnson Elevated to Co-Chair of UPCEA Committee Exciting news has emerged from the educational landscape as McCeil Johnson, J.D., the Vice President of Accreditation and Regulatory Compliance at University of Phoenix, has been chosen to serve as the co-chair of the Diversity and Inclusive Excellence Committee of UPCEA. This committee plays a vital role in shaping...

Continue Reading
Rival Technologies Unveils Innovative Program for AI Insights

Updated Category News Views 133

Rival Technologies Unveils a Leading-Edge AI Transformation Program Rival Technologies recently announced a groundbreaking initiative called the Innovation Insiders Program, which is tailored to empower market research teams to shift from theoretical AI concepts to practical applications. This program features a cohort that began its journey with significant players in...

Continue Reading
First BanCorp Plans 2024 Fourth Quarter Financial Results

Updated Category News Views 116

First BanCorp's Upcoming Financial Report First BanCorp (NYSE: FBP), the bank holding company for FirstBank Puerto Rico, is gearing up to announce its financial results for the fourth quarter of 2024. The announcement is scheduled for January 23, 2025, prior to the market opening. This quarterly report is keenly anticipated by investors and stakeholders who follow the...

Continue Reading
Amerigo Resources Achieves Solid Q3 2025 Copper Production

Updated Category News Views 244

Highlights of Q3 2025 Results In the most recent quarterly report, Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) announced impressive copper production figures for the third quarter of 2025. The company successfully produced 14.6 million pounds of copper. These results reflect a stable production capacity despite recent operational challenges related to sourcing fresh...

Continue Reading
Tenaya Therapeutics Unveils New Stock Options for Employees

Updated Category News Views 451

Tenaya Therapeutics Announces New Stock Options Tenaya Therapeutics Inc. (NASDAQ: TNYA), a leading biotechnology firm focused on groundbreaking solutions for heart disease, has recently made headlines with the announcement of stock options granted to new employees. This strategic initiative is part of the company’s commitment to attract top talent essential for...

Continue Reading